Dialanyl Calcium P-Diag 4.25%

Adult dosage

For adults, inject 1.5~2.5L into the abdominal cavity and drain after retaining for 4~8 hours, repeating this process 3~5 times a day.

This medication is intended for peritoneal dialysis, and stopping peritoneal dialysis prematurely without receiving alternative renal replacement therapy can pose life-threatening risks. This drug should not be administered to certain patients, including those with diaphragm defects, abdominal burns, severe inflammation, or severe peritoneal adhesions. Additionally, patients with hemorrhagic tendencies or suspected lactic acidosis, severe hypokalemia or hypocalcemia, or those who have recently undergone abdominal surgery should not use this medication. Caution should be exercised when administering this drug to patients on digitalis preparations or those with glucose metabolism disorders, patients using colostomies, or those currently on diuretics; their serum potassium levels or blood glucose levels should be monitored regularly. Peritonitis can occur, so the drug must be manipulated aseptically in a clean environment, and administration should occur under the supervision of qualified healthcare personnel. Pain, bleeding, or inflammation at the injection site may occur, along with gastrointestinal symptoms, electrolyte imbalances, or metabolic disorders; any abnormal symptoms should be reported immediately. During peritoneal dialysis, routinely monitor weight, nutritional status, and serum electrolyte levels; be attentive to weight measurements to prevent excessive fluid accumulation or dehydration. This drug may interact with other medications, so care should be taken when co-administering calcium or vitamin D-containing medications due to the risk of hypercalcemia. Women who are pregnant or breastfeeding should only use this drug if the benefits outweigh the risks, as its safety has not been established. In children, the dosage of the dialysis solution should be adjusted according to age and weight, and the risk of hernia in the elderly should be considered in advance. In cases of overdose, symptoms such as dehydration, electrolyte disturbances, and hyperglycemia may occur, so exchanges of the dialysis solution should be performed at appropriate speed and frequency, and any abnormal symptoms should be immediately discussed with healthcare professionals. The peritoneal dialysis solution should be used from undamaged containers, and if the container is damaged or the solution is cloudy, it should not be used; sterility must always be maintained. For peritoneal dialysis only, it should be warmed to body temperature before use, and any remaining dialysis solution should not be reused.

Serious side effects

• Peritonitis (abdominal pain, cloudy effluent, possible fever) - Severe allergic reactions
• Respiratory difficulties in patients with diaphragm defects - Respiratory issues
• Intestinal obstruction - Severe edema or urinary abnormality
• Sepsis - Severe allergic reactions due to infection
• Pulmonary edema - Respiratory issues
• Peritonitis - Severe skin allergic reactions (including febrile symptoms of peritonitis)
• Fluid overload and azotemia due to peritonitis - Severe edema or urinary abnormality

Mild side effects

• Abdominal pain, bleeding, peritonitis (abdominal pain, cloudy effluent sometimes accompanied by fever), inflammation around the abdominal catheter (redness, discharge), subcutaneous edema in case of catheter fracture or drainage difficulties
• Nausea, abdominal pain, diarrhea, constipation, hemorrhoids, vomiting, loss of appetite, abdominal distension, intestinal obstruction
• Hypokalemia, hyponatremia, hypocalcemia, hypophosphatemia, hyperlactatemia, hypomagnesemia
• Hypercholesterolemia, hypertriglyceridemia, metabolic acidosis

This medication should be stored in a sealed container to prevent air from entering, ideally kept at room temperature between 1 degree and 30 degrees Celsius. Storing it this way will help maintain the effectiveness of the medication for a long time.

Appearance

It is a colorless, transparent liquid packed in a clear polyvinyl chloride bag with a light yellow tint, sealed tightly. 2L/2 bags (Continuous Ambulatory Peritoneal Dialysis) includes injection line, internal plug, clamp, Y-junction, and cover.

Package unit

2000ml/2 bags